The Clinicopathological Significance of miR-133a in Colorectal Cancer

This study determined the expression of microRNA-133a (MiR-133a) in colorectal cancer (CRC) and adjacent normal mucosa samples and evaluated its clinicopathological role in CRC. The expression of miR-133a in 125 pairs of tissue samples was analyzed by quantitative real-time polymerase chain reaction...

Full description

Bibliographic Details
Main Authors: Wan, Timothy Ming-Hun, Lam, Colin Siu-Chi, Ng, Lui, Chow, Ariel Ka-Man, Wong, Sunny Kit-Man, Li, Hung-Sing, Man, Johnny Hon-Wai, Lo, Oswens Siu-Hung, Foo, Dominic, Cheung, Alvin, Yau, Thomas, Poon, Jensen Tung-Chung, Poon, Ronnie Tung-Ping, Law, Wai-Lun, Pang, Roberta Wen-Chi
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101241/
id pubmed-4101241
recordtype oai_dc
spelling pubmed-41012412014-08-07 The Clinicopathological Significance of miR-133a in Colorectal Cancer Wan, Timothy Ming-Hun Lam, Colin Siu-Chi Ng, Lui Chow, Ariel Ka-Man Wong, Sunny Kit-Man Li, Hung-Sing Man, Johnny Hon-Wai Lo, Oswens Siu-Hung Foo, Dominic Cheung, Alvin Yau, Thomas Poon, Jensen Tung-Chung Poon, Ronnie Tung-Ping Law, Wai-Lun Pang, Roberta Wen-Chi Research Article This study determined the expression of microRNA-133a (MiR-133a) in colorectal cancer (CRC) and adjacent normal mucosa samples and evaluated its clinicopathological role in CRC. The expression of miR-133a in 125 pairs of tissue samples was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and correlated with patient's clinicopathological data by statistical analysis. Endogenous expression levels of several potential target genes were determined by qRT-PCR and correlated using Pearson's method. MiR-133a was downregulated in 83.2% of tumors compared to normal mucosal tissue. Higher miR-133a expression in tumor tissues was associated with development of distant metastasis, advanced Dukes and TNM staging, and poor survival. The unfavorable prognosis of higher miR-133a expression was accompanied by dysregulation of potential miR-133a target genes, LIM and SH3 domain protein 1 (LASP1), Caveolin-1 (CAV1), and Fascin-1 (FSCN1). LASP1 was found to possess a negative correlation (γ = −0.23), whereas CAV1 exhibited a significant positive correlation (γ = 0.27), and a stronger correlation was found in patients who developed distant metastases (γ = 0.42). In addition, a negative correlation of FSCN1 was only found in nonmetastatic patients. In conclusion, miR-133a was downregulated in CRC tissues, but its higher expression correlated with adverse clinical characteristics and poor prognosis. Hindawi Publishing Corporation 2014 2014-07-01 /pmc/articles/PMC4101241/ /pubmed/25104873 http://dx.doi.org/10.1155/2014/919283 Text en Copyright © 2014 Timothy Ming-Hun Wan et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Wan, Timothy Ming-Hun
Lam, Colin Siu-Chi
Ng, Lui
Chow, Ariel Ka-Man
Wong, Sunny Kit-Man
Li, Hung-Sing
Man, Johnny Hon-Wai
Lo, Oswens Siu-Hung
Foo, Dominic
Cheung, Alvin
Yau, Thomas
Poon, Jensen Tung-Chung
Poon, Ronnie Tung-Ping
Law, Wai-Lun
Pang, Roberta Wen-Chi
spellingShingle Wan, Timothy Ming-Hun
Lam, Colin Siu-Chi
Ng, Lui
Chow, Ariel Ka-Man
Wong, Sunny Kit-Man
Li, Hung-Sing
Man, Johnny Hon-Wai
Lo, Oswens Siu-Hung
Foo, Dominic
Cheung, Alvin
Yau, Thomas
Poon, Jensen Tung-Chung
Poon, Ronnie Tung-Ping
Law, Wai-Lun
Pang, Roberta Wen-Chi
The Clinicopathological Significance of miR-133a in Colorectal Cancer
author_facet Wan, Timothy Ming-Hun
Lam, Colin Siu-Chi
Ng, Lui
Chow, Ariel Ka-Man
Wong, Sunny Kit-Man
Li, Hung-Sing
Man, Johnny Hon-Wai
Lo, Oswens Siu-Hung
Foo, Dominic
Cheung, Alvin
Yau, Thomas
Poon, Jensen Tung-Chung
Poon, Ronnie Tung-Ping
Law, Wai-Lun
Pang, Roberta Wen-Chi
author_sort Wan, Timothy Ming-Hun
title The Clinicopathological Significance of miR-133a in Colorectal Cancer
title_short The Clinicopathological Significance of miR-133a in Colorectal Cancer
title_full The Clinicopathological Significance of miR-133a in Colorectal Cancer
title_fullStr The Clinicopathological Significance of miR-133a in Colorectal Cancer
title_full_unstemmed The Clinicopathological Significance of miR-133a in Colorectal Cancer
title_sort clinicopathological significance of mir-133a in colorectal cancer
description This study determined the expression of microRNA-133a (MiR-133a) in colorectal cancer (CRC) and adjacent normal mucosa samples and evaluated its clinicopathological role in CRC. The expression of miR-133a in 125 pairs of tissue samples was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and correlated with patient's clinicopathological data by statistical analysis. Endogenous expression levels of several potential target genes were determined by qRT-PCR and correlated using Pearson's method. MiR-133a was downregulated in 83.2% of tumors compared to normal mucosal tissue. Higher miR-133a expression in tumor tissues was associated with development of distant metastasis, advanced Dukes and TNM staging, and poor survival. The unfavorable prognosis of higher miR-133a expression was accompanied by dysregulation of potential miR-133a target genes, LIM and SH3 domain protein 1 (LASP1), Caveolin-1 (CAV1), and Fascin-1 (FSCN1). LASP1 was found to possess a negative correlation (γ = −0.23), whereas CAV1 exhibited a significant positive correlation (γ = 0.27), and a stronger correlation was found in patients who developed distant metastases (γ = 0.42). In addition, a negative correlation of FSCN1 was only found in nonmetastatic patients. In conclusion, miR-133a was downregulated in CRC tissues, but its higher expression correlated with adverse clinical characteristics and poor prognosis.
publisher Hindawi Publishing Corporation
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101241/
_version_ 1613114872083513344